Remdesivir Market Industry Trends And Emerging Opportunities Till 2030

1
Remdesivir Market Global Report 2020-30 COVID
19 Growth And Change
2
Remdesivir Market Characteristics

• Gileads antiviral remdesivir is being tested in
  multiple phase 3 clinical trials as a treatment
  for moderately and severely ill COVID-19
  patients. Until January, the company wasnt
  manufacturing more than a few doses of its
  experimental antiviral remdesivir, but currently,
  Gilead began advancing remdesivir and is rapidly
  expanding its production as the research showed
  that remdesivir might be effective against
  COVID-19. Gilead spent 50 million on research
  and development of the drug during the first
  quarter. The company expects to produce more than
  140,000 rounds of its 10-day treatment regimen by
  the end of May. Gilead released preliminary
  results from its clinical trial on remdesivir,
  showing at least 50 of the patients treated with
  a five-day dosage of the drug have improved. The
  clinical trial involved 397 patients with severe
  cases of COVID-19. Gilead will focus on making
  remdesivir both accessible and affordable to
  governments and patients around the world. Taking
  into consideration the RD investment, and the
  affordable price range, the drug is expected to
  generate an estimated 2 billion in sales in
  2020. It is expected to grow at 29.02 and reach
  4.2 billion in 2023. The revenue will then drop
  off in subsequent years.
• The Business Research Company published its
  Remdesivir Global Market Report 2020 which
  provides strategists, marketers and senior
  management with the critical information they
  need to assess the global Remdesivir market. The
  report covers the Remdesivir markets segments-
  by route of administration into oral,
  intravenous, by dosage form into tablets, frozen
  solution, lyophilized solution and by
  distribution channel into hospitals, clinics,
  drug stores/pharmacies, online, others.
• The major regions included in the report are
  Asia-Pacific, Western Europe, Eastern Europe,
  North America, South America, Middle East, and
  Africa.

Click Here To View Complete Report
3
Major Key PlayersGilead Sciences,
Inc., Bright Gene,Hainan Haiyao, Kelun Pharma,
Click Here To Get A Sample Report
4
Table Of Content

• 1. Executive Summary
• 2. Remdesivir Market Characteristics
• 3. Remdesivir Market Size And Growth
• 4. Remdesivir Market Segmentation
• 5. Remdesivir Market Regional And Country
  Analysis
• .......
• 24. Africa Remdesivir Market
• 25. Remdesivir Market Competitive Landscape And
  Company Profiles
• 26. Key Mergers And Acquisitions In The
  Remdesivir Market
• 27. Remdesivir Market Trends And Strategies
• 28. Remdesivir Market Future Outlook and
  Potential Analysis
• 29. Appendix
• Click Here To Get A Sample Report

5
Get In Touch
Whatever your need be, at The Business Research
Company we provide research consulting solutions
for businesses, government agencies
consultancies, and market research companies.
6
Europe The Business Research Company 47
Anchorage Point, 42 Cuba Street, Canary Wharf,
London, England, E14 8NE. 44 207 1930
708 Email info_at_tbrc.info www.tbrc.info
Asia The Business Research Company, Horizon
Avenue, 8-2-603/b/s/1/2 Road Number 10 Banjara
Hills Hyderabad (India) 500033 91
8897263534 Email info_at_tbrc.info www.tbrc.info
Americas The Business Research Company 625 South
Avenue, Apt B204, Secane, Philadelphia, PA 19018,
USA 1 3156230293 Email info_at_tbrc.info www.tbrc.
info